Liver Transplantation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

Description

The global liver transplantation market is set to witness significant growth, driven by advancements in surgical procedures, increasing incidences of liver diseases, and the adoption of innovative organ preservation technologies. With a projected market value of USD 1.71 billion in 2025 and USD 2.74 billion in 2032, the market is expected to expand at a CAGR of 6.90% during the forecast period. Liver transplantation remains a critical and life-saving intervention, offering renewed hope for patients suffering from end-stage liver diseases and acute liver failure.

Market Insights

Liver transplantation has evolved into a well-established medical procedure, providing a viable solution for patients facing terminal liver conditions. The demand for transplantation services continues to surge due to rising cases of cirrhosis, hepatocellular carcinoma, and other liver disorders. Innovations in organ transplantation, coupled with an increasing number of living and deceased donor transplants, are enhancing the accessibility and success rates of these procedures.

Market Growth Drivers

1. Advancements in Surgical Techniques - Improvements in minimally invasive procedures, precision surgical instruments, and enhanced transplantation methodologies are reducing post-operative complications and improving patient outcomes.
2. Expansion of Donor Pool - Adoption of living donor liver transplantation and the use of extended criteria donor organs are increasing the availability of transplantable livers.
3. Technological Innovations in Organ Preservation - The development of machine perfusion systems and cryopreservation techniques is improving donor organ viability, ensuring better matching and successful transplantation.
4. Rising Prevalence of Liver Diseases - The increasing incidence of liver diseases due to alcohol consumption, obesity, and hepatitis is fueling demand for liver transplantation procedures.

Business Opportunities

1. Innovations in Organ Preservation - Advanced perfusion technologies can significantly increase the shelf life and quality of donor livers, opening new revenue streams for medical device manufacturers.
2. Expansion of Living Donor Liver Transplantation (LDLT) Programs - Promoting LDLT can help address organ shortages and improve access to timely transplants.
3. Integration of Artificial Intelligence (AI) in Transplantation - AI-driven pre-transplant evaluations can enhance donor-recipient matching accuracy, optimizing transplantation success rates.
4. Regenerative Medicine and Xenotransplantation - Ongoing research into bioengineered livers and animal organ transplantation may provide long-term solutions to donor organ shortages.

Market Restraints

1. Immunological Challenges - Organ rejection remains a significant challenge despite advancements in immunosuppressive therapies.
2. Organ Shortages and Procurement Complexities - The demand for liver transplants continues to outpace the supply of donor organs, necessitating better allocation and procurement systems.
3. High Cost of Transplantation - The substantial financial burden associated with liver transplantation procedures and post-surgery care remains a barrier to widespread adoption.

Regional Analysis

1. North America - The region leads in liver transplantation due to its advanced healthcare infrastructure, high awareness, and well-established organ donation programs.
2. Europe - A dominating market driven by robust transplant networks, strong regulatory frameworks, and innovative research collaborations.
3. South Asia & Pacific - Expected to be the fastest-growing region, fueled by increasing healthcare investments, rising disease prevalence, and improving access to transplantation services.
4. Middle East & Africa - Emerging opportunities in developing transplant centers and improving healthcare accessibility.

Competitive Analysis

Leading players in the global liver transplantation market are actively investing in research, development, and partnerships to enhance transplant success rates and optimize patient outcomes. Key industry participants include:

Allosource
Conatus Pharmaceuticals Inc.
Digna Biotech S.L.
Dompe Farmaceutici S.p.A.
Isogenis, Inc.
RedHill Biopharma Ltd.
Thompson Surgical
Integra Life Sciences
Baxter International Inc.
XVIVO
VirTech Bio
Vital Therapies
HepaTx

Recent Industry Developments

1. XVIVO's Liver Assist Device Receives FDA Breakthrough Device Designation (2022)

The device utilizes oxygenated machine perfusion for donor liver preservation, marking a significant advancement in transplant outcomes. Market Impact: Positions XVIVO as a key player in the evolving liver transplantation Analysis.

2. Rela Hospital Recognized for Excellence in Liver Transplants (2022)

Awarded by the Transplant Authority of Tamil Nadu for performing the highest number of pediatric liver transplants under the Chief Minister's Comprehensive Health Insurance Scheme. Market Impact: Reinforces the hospital's reputation and increases patient trust in its transplant services.

Market Segmentation

By Product Type:

Organ Preservation Solutions
Immunosuppressive Drugs
Others

By Treatment Type:

Liver Transplantation Surgery
Post-Surgery Anti-Rejection Treatment (Cyclosporine, Tacrolimus, Sirolimus, Prednisone, Azathioprine, Mycophenolate Mofetil)

By End-use:

Hospitals
Adult Liver Transplantation Centers
Ambulatory Surgical Centers

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Liver Transplantation Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. Price Analysis, 2019 - 2024

3.1. Global Average Price Analysis by Product Type, 2019 - 2024
3.2. Prominent Factor Affecting Liver Transplantation Prices
3.3. Global Average Price Analysis by Region

4. Global Liver Transplantation Market Outlook, 2019 - 2032

4.1. Global Liver Transplantation Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.1.1. Key Highlights
  - 4.1.1.1. Immunosuppressive Drugs
  - 4.1.1.2. Organ Preservation Solutions
  - 4.1.1.3. Others
4.2. Global Liver Transplantation Market Outlook, by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.2.1. Key Highlight
  - 4.2.1.1. Tacrolimus
  - 4.2.1.2. Cyclosporine
  - 4.2.1.3. Mycophenolate Mofetil
  - 4.2.1.4. Liver Transplantation Surgery
  - 4.2.1.5. Post-Surgery Anti-Rejection Treatment
  - 4.2.1.6. Sirolimus Prednisone Azathioprine
4.3. Global Liver Transplantation Market Outlook, by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals
  - 4.3.1.2. Ambulatory Surgical Centers
  - 4.3.1.3. Adult Liver Transplantation Centers
4.4. Global Liver Transplantation Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.4.1. Key Highlights
  - 4.4.1.1. North America
  - 4.4.1.2. Europe
  - 4.4.1.3. Asia Pacific
  - 4.4.1.4. Latin America
  - 4.4.1.5. Middle East & Africa

5. North America Liver Transplantation Market Outlook, 2019 - 2032

5.1. North America Liver Transplantation Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.1.1. Key Highlights
  - 5.1.1.1. Immunosuppressive Drugs
  - 5.1.1.2. Organ Preservation Solutions
  - 5.1.1.3. Others
5.2. North America Liver Transplantation Market Outlook, by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.2.1. Key Highlight
  - 5.2.1.1. Tacrolimus
  - 5.2.1.2. Cyclosporine
  - 5.2.1.3. Mycophenolate Mofetil
  - 5.2.1.4. Liver Transplantation Surgery
  - 5.2.1.5. Post-Surgery Anti-Rejection Treatment
  - 5.2.1.6. Sirolimus Prednisone Azathioprine
5.3. North America Liver Transplantation Market Outlook, by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Ambulatory Surgical Centers
  - 5.3.1.3. Adult Liver Transplantation Centers
- 5.3.2. Attractiveness Analysis
5.4. North America Liver Transplantation Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.4.1. Key Highlights
  - 5.4.1.1. U.S. Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.2. U.S. Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.3. U.S. Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.4. Canada Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.5. Canada Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.6. Canada Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032

6. Europe Liver Transplantation Market Outlook, 2019 - 2032

6.1. Europe Liver Transplantation Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.1.1. Key Highlights
  - 6.1.1.1. Immunosuppressive Drugs
  - 6.1.1.2. Organ Preservation Solutions
  - 6.1.1.3. Others
6.2. Europe Liver Transplantation Market Outlook, by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.2.1. Key Highlight
  - 6.2.1.1. Tacrolimus
  - 6.2.1.2. Cyclosporine
  - 6.2.1.3. Mycophenolate Mofetil
  - 6.2.1.4. Liver Transplantation Surgery
  - 6.2.1.5. Post-Surgery Anti-Rejection Treatment
  - 6.2.1.6. Sirolimus Prednisone Azathioprine
6.3. Europe Liver Transplantation Market Outlook, by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Ambulatory Surgical Centers
  - 6.3.1.3. Adult Liver Transplantation Centers
- 6.3.2. Attractiveness Analysis
6.4. Europe Liver Transplantation Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.4.1. Key Highlights
  - 6.4.1.1. Germany Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.2. Germany Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.3. Germany Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.4. U.K. Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.5. U.K. Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.6. U.K. Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.7. France Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.8. France Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.9. France Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.10. Italy Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.11. Italy Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.12. Italy Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.13. Turkey Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.14. Turkey Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.15. Turkey Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.16. Russia Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.17. Russia Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.18. Russia Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.19. Rest of Europe Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.20. Rest of Europe Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.21. Rest of Europe Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032

7. Asia Pacific Liver Transplantation Market Outlook, 2019 - 2032

7.1. Asia Pacific Liver Transplantation Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.1.1. Key Highlights
  - 7.1.1.1. Immunosuppressive Drugs
  - 7.1.1.2. Organ Preservation Solutions
  - 7.1.1.3. Others
7.2. Asia Pacific Liver Transplantation Market Outlook, by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.2.1. Key Highlight
  - 7.2.1.1. Tacrolimus
  - 7.2.1.2. Cyclosporine
  - 7.2.1.3. Mycophenolate Mofetil
  - 7.2.1.4. Liver Transplantation Surgery
  - 7.2.1.5. Post-Surgery Anti-Rejection Treatment
  - 7.2.1.6. Sirolimus Prednisone Azathioprine
7.3. Asia Pacific Liver Transplantation Market Outlook, by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Ambulatory Surgical Centers
  - 7.3.1.3. Adult Liver Transplantation Centers
- 7.3.2. Attractiveness Analysis
7.4. Asia Pacific Liver Transplantation Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.4.1. Key Highlights
  - 7.4.1.1. China Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.2. China Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.3. China Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.4. Japan Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.5. Japan Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.6. Japan Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.7. South Korea Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.8. South Korea Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.9. South Korea Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.10. India Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.11. India Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.12. India Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.13. Southeast Asia Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.14. Southeast Asia Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.15. Southeast Asia Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.16. Rest of Asia Pacific Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.17. Rest of Asia Pacific Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.18. Rest of Asia Pacific Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032

8. Latin America Liver Transplantation Market Outlook, 2019 - 2032

8.1. Latin America Liver Transplantation Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.1.1. Key Highlights
  - 8.1.1.1. Immunosuppressive Drugs
  - 8.1.1.2. Organ Preservation Solutions
  - 8.1.1.3. Others
8.2. Latin America Liver Transplantation Market Outlook, by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.2.1. Key Highlight
  - 8.2.1.1. Tacrolimus
  - 8.2.1.2. Cyclosporine
  - 8.2.1.3. Mycophenolate Mofetil
  - 8.2.1.4. Liver Transplantation Surgery
  - 8.2.1.5. Post-Surgery Anti-Rejection Treatment
  - 8.2.1.6. Sirolimus Prednisone Azathioprine
8.3. Latin America Liver Transplantation Market Outlook, by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Ambulatory Surgical Centers
  - 8.3.1.3. Adult Liver Transplantation Centers
- 8.3.2. Attractiveness Analysis
8.4. Latin America Liver Transplantation Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.4.1. Key Highlights
  - 8.4.1.1. Brazil Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.2. Brazil Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.3. Brazil Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.4. Mexico Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.5. Mexico Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.6. Mexico Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.7. Argentina Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.8. Argentina Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.9. Argentina Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.10. Rest of Latin America Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.11. Rest of Latin America Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.12. Rest of Latin America Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Liver Transplantation Market Outlook, 2019 - 2032

9.1. Middle East & Africa Liver Transplantation Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.1.1. Key Highlights
  - 9.1.1.1. Immunosuppressive Drugs
  - 9.1.1.2. Organ Preservation Solutions
  - 9.1.1.3. Others
9.2. Middle East & Africa Liver Transplantation Market Outlook, by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.2.1. Key Highlight
  - 9.2.1.1. Tacrolimus
  - 9.2.1.2. Cyclosporine
  - 9.2.1.3. Mycophenolate Mofetil
  - 9.2.1.4. Liver Transplantation Surgery
  - 9.2.1.5. Post-Surgery Anti-Rejection Treatment
  - 9.2.1.6. Sirolimus Prednisone Azathioprine
9.3. Middle East & Africa Liver Transplantation Market Outlook, by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.3.1. Key Highlights
  - 9.3.1.1. Hospitals
  - 9.3.1.2. Ambulatory Surgical Centers
  - 9.3.1.3. Adult Liver Transplantation Centers
- 9.3.2. Attractiveness Analysis
9.4. Middle East & Africa Liver Transplantation Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.4.1. Key Highlights
  - 9.4.1.1. GCC Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.2. GCC Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.3. GCC Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.4. South Africa Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.5. South Africa Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.6. South Africa Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.7. Egypt Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.8. Egypt Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.9. Egypt Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.10. Nigeria Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.11. Nigeria Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.12. Nigeria Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.13. Rest of Middle East & Africa Liver Transplantation Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.14. Rest of Middle East & Africa Liver Transplantation Market by Treatment Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.15. Rest of Middle East & Africa Liver Transplantation Market by End-use, Value (US$ Bn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

10.1. By Product Type vs by Treatment Type Heatmap
10.2. Company Market Share Analysis, 2025
10.3. Competitive Dashboard
10.4. Company Profiles
- 10.4.1. AlloSource
  - 10.4.1.1. Company Overview
  - 10.4.1.2. Product Portfolio
  - 10.4.1.3. Financial Overview
  - 10.4.1.4. Business Strategies and Development
- 10.4.2. Conatus Pharmaceuticals Inc.
  - 10.4.2.1. Company Overview
  - 10.4.2.2. Product Portfolio
  - 10.4.2.3. Financial Overview
  - 10.4.2.4. Business Strategies and Development
- 10.4.3. Digna Biotech S.L.
  - 10.4.3.1. Company Overview
  - 10.4.3.2. Product Portfolio
  - 10.4.3.3. Financial Overview
  - 10.4.3.4. Business Strategies and Development
- 10.4.4. Dompe Farmaceutici S.p.A.
  - 10.4.4.1. Company Overview
  - 10.4.4.2. Product Portfolio
  - 10.4.4.3. Financial Overview
  - 10.4.4.4. Business Strategies and Development
- 10.4.5. Isogenis, Inc.
  - 10.4.5.1. Company Overview
  - 10.4.5.2. Product Portfolio
  - 10.4.5.3. Financial Overview
  - 10.4.5.4. Business Strategies and Development
- 10.4.6. RedHill Biopharma Ltd.
  - 10.4.6.1. Company Overview
  - 10.4.6.2. Product Portfolio
  - 10.4.6.3. Financial Overview
  - 10.4.6.4. Business Strategies and Development
- 10.4.7. Thompson Surgical
  - 10.4.7.1. Company Overview
  - 10.4.7.2. Product Portfolio
  - 10.4.7.3. Financial Overview
  - 10.4.7.4. Business Strategies and Development
- 10.4.8. Integra Life Sciences
  - 10.4.8.1. Company Overview
  - 10.4.8.2. Product Portfolio
  - 10.4.8.3. Financial Overview
  - 10.4.8.4. Business Strategies and Development
- 10.4.9. Baxter International Inc.
  - 10.4.9.1. Company Overview
  - 10.4.9.2. Product Portfolio
  - 10.4.9.3. Financial Overview
  - 10.4.9.4. Business Strategies and Development
- 10.4.10. XVIVO
  - 10.4.10.1. Company Overview
  - 10.4.10.2. Product Portfolio
  - 10.4.10.3. Financial Overview
  - 10.4.10.4. Business Strategies and Development
- 10.4.11. VirTech Bio
  - 10.4.11.1. Company Overview
  - 10.4.11.2. Product Portfolio
  - 10.4.11.3. Financial Overview
  - 10.4.11.4. Business Strategies and Development
- 10.4.12. Vital Therapies
  - 10.4.12.1. Company Overview
  - 10.4.12.2. Product Portfolio
  - 10.4.12.3. Financial Overview
  - 10.4.12.4. Business Strategies and Development
- 10.4.13. HepaTx
  - 10.4.13.1. Company Overview
  - 10.4.13.2. Product Portfolio
  - 10.4.13.3. Financial Overview
  - 10.4.13.4. Business Strategies and Development

11. Appendix

11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations